Molecular basis of rifampicin resistance in methicillin-resistant Staphylococcus pseudintermedius isolates from dogs

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 6, 2011, Pages 1236-1242

  Kadlec, Kristina ^a   van Duijkeren, Engeline ^b   Wagenaar, Jaap A ^b   Schwarz, Stefan ^a  

^a FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Antimicrobial agents; MRSP; Multiresistance; Mutation; RpoB gene

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFALOTIN; CEFOPERAZONE; CEFOTAXIME; CEFQUINOME; CEFTIOFUR; CHLORAMPHENICOL; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ENROFLOXACIN; ERYTHROMYCIN; FLORFENICOL; FUSIDIC ACID; GENTAMICIN; OXACILLIN; PENICILLIN G; PIRLIMYCIN; RIFAMPICIN; SPECTINOMYCIN; SPIRAMYCIN; TETRACYCLINE; TIAMULIN; TILMICOSIN; TRIMETHOPRIM; TULATHROMYCIN; TYLOSIN; UNINDEXED DRUG; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; DERMATITIS; DOG; EXTERNAL OTITIS; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; METHICILLIN RESISTANT STAPHYLOCOCCUS PSEUDINTERMEDIUS; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR TYPING; NONHUMAN; PARONYCHIA; POLYMERASE CHAIN REACTION; PROTEIN STRUCTURE, FUNCTION AND VARIABILITY; PYODERMA; RIFAMPICIN RESISTANCE DETERMINING REGION; SPECIES IDENTIFICATION; STAPHYLOCOCCUS; STAPHYLOCOCCUS INFECTION; TREATMENT DURATION; WOUND INFECTION;

ANIMALS; BACTERIAL TYPING TECHNIQUES; DNA MUTATIONAL ANALYSIS; DNA, BACTERIAL; DNA-DIRECTED RNA POLYMERASES; DOG DISEASES; DOGS; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR TYPING; MUTATION, MISSENSE; POLYMERASE CHAIN REACTION; RIFAMPIN; SEQUENCE ANALYSIS, DNA; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS;

EID: 79955992714     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr118     Document Type: Article

References (22)

1. Weese JS, van Duijkeren E. Methicillin-resistant Staphylococcus aureus and Staphylococcus pseudintermedius in veterinary medicine. Vet Microbiol 2010; 140: 418-29.
2. Perreten V, Kadlec K, Schwarz S et al. Clonal spread of methicillin-resistant Staphylococcus pseudintermedius in Europe and North America: an international multicentre study. J Antimicrob Chemother 2010; 65: 1145-54.
3. Boost MV, So SY, Perreten V. Low rate of methicillin-resistant coagulase-positive staphylococcal colonization of veterinary personnel in Hong Kong. Zoonoses Public Health 2011; 58: 36-40.
4. Kadlec K, Schwarz S, Perreten V et al. Molecular analysis of methicillin-resistant Staphylococcus pseudintermedius of feline origin from different European countries and North America. J Antimicrob Chemother 2010; 65: 1826-8.
5. Herrera L, Jiménez S, Valverde A et al. Molecular analysis of rifampicin-resistant Mycobacterium tuberculosis isolated in Spain (1996-2001). Description of new mutations in the rpoB gene and review of the literature. Int J Antimicrob Agents 2003; 21: 403-8.
6. Aubry-Damon H, Soussy CJ, Courvalin P. Characterization of mutations in the rpoB gene that confer rifampin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 1998; 42: 2590-4.
7. Bannoehr J, Franco A, Iurescia M et al. Molecular diagnostic identification of Staphylococcus pseudintermedius. J Clin Microbiol 2008; 47: 469-71.
8. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals-Third Edition: Approved Standard M31-A3. CLSI, Wayne, PA, USA, 2008.
9. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twentieth Informational Supplement M100-S20. CLSI, Wayne, PA, USA, 2010.
10. Kadlec K, Ehricht R, Monecke S et al. Diversity of antimicrobial resistance pheno- and genotypes of methicillin-resistant Staphylococcus aureus ST398 from diseased swine. J Antimicrob Chemother 2009; 64: 1156-64.
11. Drancourt M, Raoult D. rpoB gene sequence-based identification of Staphylococcus species. J Clin Microbiol 2002; 40: 1333-8.
12. Schwarz S, Silley P, Simjee S et al. Assessing the antimicrobial susceptibility of bacteria obtained from animals. J Antimicrob Chemother 2010; 65: 601-4.
13. Falagas ME, Bliziotis IA, Fragoulis KN. Oral rifampin for eradication of Staphylococcus aureus carriage from healthy and sick populations: a systematic review of the evidence from comparative trials. Am J Infect Control 2007; 35: 106-14.
14. Wichelhaus TA, Böddinghaus B, Besier S et al. Biological cost of rifampin resistance from the perspective of Staphylococcus aureus. Antimicrob Agents Chemother 2002; 46: 3381-5.
15. Enne VI, Delsol AA, Roe JM et al. Rifampicin resistance and its fitness cost in Enterococcus faecium. J Antimicrob Chemother 2004; 53: 203-7.
16. Fines M, Pronost S, Maillard K et al. Characterization of mutations in the rpoB gene associated with rifampin resistance in Rhodococcus equi isolated from foals. J Clin Microbiol 2001; 39: 2784-7.
17. Asoh N, Watanabe H, Fines-Guyon M et al. Emergence of rifampin-resistant Rhodococcus equi with several types of mutations in the rpoB gene among AIDS patients in Northern Thailand. J Clin Microbiol 2003; 41: 2337-40.
18. Caws M, Duy PM, Tho DQ et al. Mutations prevalent among rifampinand isoniazid-resistant Mycobacterium tuberculosis isolates from a hospital in Vietnam. J Clin Microbiol 2006; 44: 2333-7.
19. Afanas'ev MV, Ikryannikova LN, Il'ina EN et al. Molecular characteristics of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis isolates from the Russian Federation. J Antimicrob Chemother 2007; 59: 1057-64.
20. Zhang Y, Yew WW. Mechanisms of drug resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2009; 13: 1320-30.
21. Telenti A, Imboden P, Marchesi F et al. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 1993; 341: 647-50.
22. Şentürk S, Özel E, Şen A. Clinical efficacy of rifampicin for treatment of canine pyoderma. Acta Vet Brno 2005; 74: 117-22.